In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Svetlana A IvanovaMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.ORCID 0000-0001-7078-323X Vladimir V TiguntsevMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.
Anastasia S BoikoMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.ORCID 0000-0002-2955-9057 Ekaterina V MikhalitskayaMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.ORCID 0000-0001-7085-2741 Dmitry A PetkunMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.ORCID 0009-0008-1878-5084 Irina A MednovaMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.ORCID 0000-0002-8057-3305 Olga Yu FedorenkoMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.ORCID 0000-0002-9565-6314 Nikolay A SkryabinResearch Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia.ORCID 0000-0002-2491-3141 Elena G KornetovaMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.ORCID 0000-0002-5179-9727 Alexander N KornetovMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.ORCID 0000-0002-2342-7504 Nikolay A BokhanMental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634014, Russia.
Funding
Tomsk National Research Medical Center #24/2-grant - MNI
6 · The paper itselfAbstract
The role of the genetic component in the development of schizophrenia and the formation of its clinical heterogeneity has been proven. To conduct a pilot associative analysis between positive and negative schizophrenia symptoms and polymorphic variants of the Transcription Factor 4 (
Indexed as
Genetic Predisposition to DiseasePolymorphism, Single NucleotideSchizophreniaTranscription Factor 4AdultAllelesCase-Control StudiesFemaleGene FrequencyGenotypeHumansMaleMiddle AgedPilot ProjectsTCF4 protein, humanTranscription Factor 4clinical heterogeneitymolecular geneticsschizophreniasingle nucleotide polymorphismTCF4
Identifiers
PMID41226544
PMCPMC12609942
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390